An in-depth understanding of the roles TOM components play outside of import would provide molecular insights for the pathogenesis of many cancer types, neurodegeneration, viral immunity, and mitochondrial genetic disorders that would bolster mitochondria as a therapeutic target. The gene discussed is PRPF6; the disease is inborn mitochondrial metabolism disorder.